Abstract
Purpose
A delayed release bio-polymeric Dual-Biotic system has been extensively evaluated in this study to overcome the therapeutic issue of probiotic killing due to incorrect administration with the antibiotic.
Methods
In vitro and ex vivo release and characterization studies have been undertaken on the Dual-Biotic system. In vivo analyses utilizing a Large White pig model were also performed with commercial products used as a comparison. Intestinal fluid for probiotic quantification was aspirated using a surgically implanted intestinal cannula with Lactobacillus acidophilus cell counts determined through luminescence and inoculation onto Lactobacilli-specific agar. Plasma amoxicillin concentrations were determined through Ultra-Performance Liquid Chromatography. The reactional profile and crosslinking mechanism of ovalbumin and genipin was elucidated using molecular mechanic energy relationships in a vacuum system by exploring the spatial disposition of different concentrations of genipin with respect to ovalbumin with ovalbumin/genipin ratios of 1:1, 1:5 and 1:10.
Results
In vivo evaluation of the Dual-Biotic system detailed maximum Lactobacillus viability (~455% baseline viability) 6 h after oral administration. Concurrent administration of the commercial products revealed a 75% decrease in bacterial viability when compared to the controls analyzed. A level A in vitro-in vivo correlation was also established with 96.9% predictability of amoxicillin release ascertained. The computational results achieved corroborated well with the experimental findings and physicochemical data.
Conclusions
Evaluation and correlation of the Dual-Biotic system has detailed the success of the formulation for the concurrent delivery of an antibiotic and probiotic.
Similar content being viewed by others
Abbreviations
- DBioS:
-
Dual-biotic system
- GMS:
-
Glyceryl monostereate
- MMER:
-
Molecular mechanic energy relationships
- MPCT:
-
Minimum probiotic concentration time
- PE:
-
Prediction error
References
Iannitti T, Palmieri B. Therapeutical use of probiotic formulations in clinical practice. Clin Nutr. 2010;29(6):701–25.
Lund B, Adamsson I, Edlund C. Gastrointestinal transit survival of an Enterococcus faecium probiotic strain administered with or without vancomycin. Int J Food Microbiol. 2002;77(1-2):109–15.
Yamada T, Alpers D, Kalloo AN, Kaplowitz N, Owyang C, Powell DW. Principles of clinical gastroenterology. West Sussex: Blackwell Publishing; 2008.
Govender M, Choonara YE, van Vuuren S, Kumar P, du Toit LC, Pillay V. A gastro-resistant ovalbumin bi-layered mini-tablet-in-tablet system for the delivery of Lactobacillus acidophilus probiotic to simulated human intestinal and colon conditions. J Pharm Pharmacol. 2015;67(7):939–50.
Kailasapathy K. Survival of free and encapsulated probiotic bacteria and their effect on the sensory properties of yoghurt. LWT. 2006;39(10):1221–7.
Albertini B, Vitali B, Passerini N, et al. Development of microparticulate systems for intestinal delivery of Lactobacillus acidophilus and Bifidobacterium lactis. Eur J Pharm Sci. 2010;40(4):359–66.
Witkowski G, Lode H, Hoffken G, Koeppe P. Pharmacokinetic studies of amoxicillin, potassium clavulanate and their combination. Eur J Clin Microbiol. 1982;1(4):233–7.
Lu C, Lu Y, Chen J, Zhang W, Wu W. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur J Pharm Biopharm. 2007;66(2):210–9.
Mare L, Wolfaardt GM. Dicks, LMT Adhesion of Lactobacillus plantarum 423 and Lactobacillus salivarius 241 to the intestinal tract of piglets, as recorded with fluorescent in situ hybridization (FISH), and production of plantaricin 423 by cells colonized to the ileum. J Appl Microbiol. 2006;100(4):838–45.
Poulin JF, Caillard R, Subirade M. Lactoglobulin tablets as a suitable vehicle for protection and intestinal delivery of probiotic bacteria. Int J Pharm. 2011;405(1-2):47–54.
Mehta S, De Beer T, Remon JP, Vervaet C. Effect of disintegrants on the properties of multiparticulate tablets comprising starch pellets and excipient granules. Int J Pharm. 2012;422(1-2):310–7.
Hodgson DS. Comparison of isoflurane and sevoflurane for short-term anesthesia in piglets. Vet Anaesth Analg. 2007;34(2):117–24.
Linkenhoker JR, Burkholder TH, Linton CGG, et al. Effective and Safe Anesthesia for Yorkshire and Yucatan Swine with and without Cardiovascular Injury and Intervention. J Am Assoc Lab Anim Sci. 2010;49(3):344–51.
Carlier M, Stove V, Roberts JA, Van de Velde E, De Waele JJ, Verstraete AG. Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method. Int J Antimicrob Agents. 2012;40(5):416–22.
Zhang Y, Huo M, Zhou J, Xie S. PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed. 2010;99(3):306–14.
Kumar P, Pillay V, Choonara YE, Modi G, Naidoo D, du Toit LC. In silico theoretical molecular modeling for Alzheimer’s disease: The nicotine-curcumin paradigm in neuroprotection and neurotherapy. Int J Mol Sci. 2011;12(1):694–724.
Katstra WE, Palazzolo RD, Rowe CW, Giritlioglu B, Teung P, Cima MJ. Oral dosage forms fabricated by Three Dimensional PrintingTM. J Control Release. 2000;66(1):1–9.
Nunthanid J, Laungtana-anan M, Sriamornsak P, et al. Characterization of chitosan acetate as a binder for sustained release tablets. J Control Release. 2004;99(1):15–26.
Aramwit P, Siritientong T, Kanokpanont S, Srichana T. Formulation and characterization of silk sericin–PVA scaffold crosslinked with genipin. Int J Biol Macromol. 2010;47(5):668–75.
Wang L, Wang Y, Qu J, Hu Y, You R, Li M. The cytocompatibility of Genipin-crosslinked silk fibroin films. J Biomater Nanobiotechnol. 2013;4(3):213–21.
He J, Tang S, Li L, et al. Pharmacokinetics of a novel amoxicillin⁄colistin suspension after intramuscular administration in pigs. J Vet Pharmacol Ther. 2010;34(1):42–50.
Jones A, Zeller MA, Sharma S. Thermal, mechanical, and moisture absorption properties of egg white protein bioplastics with natural rubber and glycerol. Prog Biomater. 2013;2:12.
Ravindran CA. Importance of in-vitro in-vivo studies in pharmaceutical formulation development. Der Pharm Sin. 2011;2(4):218–40.
Yu OY, Chung JW, Kwak SY. Reduced migration from flexible poly(vinyl chloride) of a plasticizer containing β-Cyclodextrin derivative. Environ Sci Technol. 2008;42(19):7522–7.
Butler MF, Ng YF, Pudney PDA. Mechanism and kinetics of the crosslinking reaction between biopolymers containing primary amine groups and genipin. J Polym Sci A Polym Chem. 2003;41(24):3941–53.
Govender M, Choonara YE, Kumar P, du Toit LC, van Vuuren S, Pillay V. A Review of the advancements in arobiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation. AAPS PharmSciTech. 2014;15(1):29–43.
Krasaekoopt W, Bhandari B, Deeth H. The influence of coating materials on some properties of alginate beads and survivability of microencapsulated probiotic bacteria. Int Dairy J. 2004;14(8):737–43.
Maragkoudakis PA, Zoumpopoulou G, Miaris C, Kalantzopoulos G, Pot B, Tsakalidou E. Probiotic potential of Lactobacillus strains isolated from dairy products. Int Dairy J. 2006;16(3):189–99.
Acknowledgments and Disclosures
This research work was funded by the National Research Foundation (NRF) of South Africa.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
Ethical clearance for this study was obtained from the Animal Ethics Screening Committee (AESC) of the University of the Witwatersrand, South Africa (Ethics Clearance no. 2012/26/05).
Rights and permissions
About this article
Cite this article
Govender, M., Choonara, Y.E., van Vuuren, S. et al. A Dual-Biotic System for the Concurrent Delivery of Antibiotics and Probiotics: In Vitro, Ex Vivo, In Vivo and In Silico Evaluation and Correlation. Pharm Res 33, 3057–3071 (2016). https://doi.org/10.1007/s11095-016-2030-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-016-2030-1